{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:29:35Z","timestamp":1795112975155,"version":"4.10.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T00:00:00Z","timestamp":1748131200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Autosomal recessive bestrophinopathy (ARB) is a rare retinal dystrophy caused by homozygous or compound heterozygous null variants in the <jats:italic>BEST1<\/jats:italic> gene. Clinically, ARB presents with variable features including central visual impairment, global photoreceptor dysfunction (as indicated by abnormal full-field ERG), and a significantly reduced electro-oculogram (EOG) light rise, a hallmark of bestrophinopathy. Fundus examination reveals widespread retinal pigment epithelial (RPE) disturbance, vitelliform deposits in the posterior pole (more clearly visualized with fundus autofluorescence), and macular fluid accumulation. Angle-closure glaucoma, secondary to anterior chamber dysgenesis, is a potential complication. This work aims at documenting the founder effect of a novel variant in the <jats:italic>BEST1<\/jats:italic> gene causing autosomal recessive bestrophinopathy and determining its variable clinical features.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Twelve members of nine unrelated, consanguineous Egyptian families with a history of impaired central vision underwent comprehensive ophthalmological examination, fundus color photography, fundus autofluorescence (FAF), spectral-domain optical coherence tomography (SD-OCT) of the macula, and electrophysiological studies. Variant screening of coding exons of the <jats:italic>BEST1<\/jats:italic> gene and some flanking regions was performed using the Sanger sequencing technique. The pathogenicity of the variants was tested using different in silico functional analysis tools.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The clinical examination and investigations confirmed the ARB phenotype. All twelve patients exhibited (c.365 G\u2009&gt;\u2009C, p. Arg122Pro) a novel <jats:italic>BEST1<\/jats:italic> gene variant in a homozygous form. On top of the classical retinal phenotype of ARB, some patients had other ocular associations: four patients were found to have angle-closure glaucoma, one patient had associated corneal dystrophy, one developed a macular hole, and one patient developed uveitis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The identification of the same, novel homozygous <jats:italic>BEST1<\/jats:italic> missense variant in twelve patients from nine unrelated, consanguineous families of Egyptian origin, suggests a founder effect. Angle-closure glaucoma was the most commonly associated ocular abnormality (30%). Our finding expands the molecular spectrum of ARB-associated variants, and identification of this founder variant can simplify genetic testing in the presence of limited resources and lead to better counseling.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03813-1","type":"journal-article","created":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T07:55:00Z","timestamp":1748159700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A novel founder variant in BEST1 gene causing autosomal recessive bestrophinopathy"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3826-9780","authenticated-orcid":false,"given":"Nagham Maher","family":"Elbagoury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Atef","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa Fawzy","family":"Abdel-Aleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba Mahmoud","family":"Fathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina Nabil","family":"Baddar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Lotfi","family":"Essawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,25]]},"reference":[{"issue":"4","key":"3813_CR1","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/sj.ejhg.5200796","volume":"10","author":"H St\u00f6hr","year":"2002","unstructured":"St\u00f6hr H, Marquardt A, Nanda I, Schmid M, Weber BH. Three novel human VMD2-like genes are members of the evolutionary highly conserved RFP-TM family. Eur J Hum Genet. 2002;10(4):281\u20134.","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"3813_CR2","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/915","volume":"19","author":"K Petrukhin","year":"1998","unstructured":"Petrukhin K, Koisti MJ, Bakall B, Li W, Xie G, Marknell T, et al. Identification of the gene responsible for best macular dystrophy. Nat Genet. 1998;19(3):241\u20137.","journal-title":"Nat Genet"},{"issue":"23","key":"3813_CR3","doi-asserted-by":"publisher","first-page":"12758","DOI":"10.1073\/pnas.220402097","volume":"97","author":"AD Marmorstein","year":"2000","unstructured":"Marmorstein AD, Marmorstein LY, Rayborn M, Wang X, Hollyfield JG, Petrukhin K. Bestrophin, the product of the best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium. Proc Natl Acad Sci U S A. 2000;97(23):12758\u201363.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3813_CR4","doi-asserted-by":"publisher","first-page":"4008","DOI":"10.1073\/pnas.052692999","volume":"99","author":"H Sun","year":"2002","unstructured":"Sun H, Tsunenari T, Yau KW, Nathans J. The vitelliform macular dystrophy protein defines a new family of chloride channels. Proc Natl Acad Sci U S A. 2002;99(6):4008\u201313.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3813_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1096\/fj.05-4495fje","volume":"20","author":"R Rosenthal","year":"2006","unstructured":"Rosenthal R, Bakall B, Kinnick T, Peachey N, Wimmers S, Wadelius C, et al. Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2\u2009+\u2009channels in retinal pigment epithelial cells. FASEB J. 2006;20(1):178\u201380.","journal-title":"FASEB J"},{"issue":"6","key":"3813_CR6","doi-asserted-by":"publisher","first-page":"C1371","DOI":"10.1152\/ajpcell.00398.2007","volume":"294","author":"Z Qu","year":"2008","unstructured":"Qu Z, Hartzell HC. Bestrophin Cl- channels are highly permeable to HCO3. Am J Physiol Cell Physiol. 2008;294(6):C1371\u20137.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"3813_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1074\/jbc.M607383200","volume":"282","author":"VM Milenkovic","year":"2007","unstructured":"Milenkovic VM, Rivera A, Horling F, Weber BH. Insertion and topology of normal and mutant bestrophin-1 in the Endoplasmic reticulum membrane. J Biol Chem. 2007;282(2):1313\u201321.","journal-title":"J Biol Chem"},{"issue":"3","key":"3813_CR8","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.preteyeres.2009.04.002","volume":"28","author":"CJ Boon","year":"2009","unstructured":"Boon CJ, Klevering BJ, Leroy BP, Hoyng CB, Keunen JE, den Hollander AI. The spectrum of ocular phenotypes caused by mutations in the BEST1 gene. Prog Retin Eye Res. 2009;28(3):187\u2013205.","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"3813_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/sj.ejhg.5200447","volume":"8","author":"F Kramer","year":"2000","unstructured":"Kramer F, White K, Pauleikhoff D, Gehrig A, Passmore L, Rivera A, et al. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration. Eur J Hum Genet. 2000;8(4):286\u201392.","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"3813_CR10","doi-asserted-by":"publisher","first-page":"3683","DOI":"10.1167\/iovs.04-0550","volume":"45","author":"J Yardley","year":"2004","unstructured":"Yardley J, Leroy BP, Hart-Holden N, Lafaut BA, Loeys B, Messiaen LM, et al. Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). Invest Ophthalmol Vis Sci. 2004;45(10):3683\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"3813_CR11","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.ajhg.2009.09.015","volume":"85","author":"AE Davidson","year":"2009","unstructured":"Davidson AE, Millar ID, Urquhart JE, Burgess-Mullan R, Shweikh Y, Parry N, et al. Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. Am J Hum Genet. 2009;85(5):581\u201392.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3813_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ajo.2005.09.018","volume":"141","author":"M Michaelides","year":"2006","unstructured":"Michaelides M, Urquhart J, Holder GE, Restori M, Kayali N, Manson FD, et al. Evidence of genetic heterogeneity in MRCS (microcornea, rod-cone dystrophy, cataract, and posterior staphyloma) syndrome. Am J Ophthalmol. 2006;141(2):418\u201320.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"3813_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1080\/13816810600677990","volume":"27","author":"P Schatz","year":"2006","unstructured":"Schatz P, Klar J, Andreasson S, Ponjavic V, Dahl N. Variant phenotype of best vitelliform macular dystrophy associated with compound heterozygous mutations in VMD2. Ophthalmic Genet. 2006;27(2):51\u20136.","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"3813_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ajhg.2007.08.004","volume":"82","author":"R Burgess","year":"2008","unstructured":"Burgess R, Millar ID, Leroy BP, Urquhart JE, Fearon IM, De Baere E, et al. Biallelic mutation of BEST1 causes a distinct retinopathy in humans. Am J Hum Genet. 2008;82(1):19\u201331.","journal-title":"Am J Hum Genet"},{"issue":"13","key":"3813_CR15","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1167\/iovs.15-18168","volume":"56","author":"CS Lee","year":"2015","unstructured":"Lee CS, Jun I, Choi SI, Lee JH, Lee MG, Lee SC, et al. A novel BEST1 mutation in autosomal recessive bestrophinopathy. Invest Ophthalmol Vis Sci. 2015;56(13):8141\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"3813_CR16","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.ophtha.2020.04.008","volume":"127","author":"N Pontikos","year":"2020","unstructured":"Pontikos N, Arno G, Jurkute N, Schiff E, Ba-Abbad R, Malka S, et al. Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the united Kingdom. Ophthalmology. 2020;127(10):1384\u201394.","journal-title":"Ophthalmology"},{"issue":"11","key":"3813_CR17","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1093\/bioinformatics\/bty897","volume":"35","author":"C Kopanos","year":"2019","unstructured":"Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Aguilera MA, Meyer R, et al. VarSome: the human genomic variant search engine. Bioinformatics. 2019;35(11):1978.","journal-title":"Bioinformatics"},{"key":"3813_CR18","unstructured":"Wallis Y, Payne S, McAnulty C, Bodmer D, Sistermans E, Robertson K, et al. Practice guidelines for the evaluation of pathogenicity and the reporting of sequence variants in clinical molecular genetics. Association for Clinical Genetic Science and the Dutch Society of Clinical Genetic Laboratory Specialists; 2013."},{"key":"3813_CR19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/1471-2105-11-548","volume":"11","author":"H Venselaar","year":"2010","unstructured":"Venselaar H, Te Beek TA, Kuipers RK, Hekkelman ML, Vriend G. Protein structure analysis of mutations causing inheritable diseases. An e-Science approach with life scientist friendly interfaces. BMC Bioinformatics. 2010;11:548.","journal-title":"BMC Bioinformatics"},{"issue":"13","key":"3813_CR20","first-page":"2672","volume":"25","author":"Y Moshfegh","year":"2016","unstructured":"Moshfegh Y, Velez G, Li Y, Bassuk AG, Mahajan VB, Tsang SH. BESTROPHIN1 mutations cause defective chloride conductance in patient stem cell-derived RPE. Hum Mol Genet. 2016;25(13):2672\u201380.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"3813_CR21","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1080\/19336950.2021.1981625","volume":"15","author":"AP Owji","year":"2021","unstructured":"Owji AP, Kittredge A, Zhang Y, Yang T. Structure and function of the Bestrophin family of calcium-activated chloride channels. Channels. 2021;15(1):604\u201323.","journal-title":"Channels"},{"issue":"1","key":"3813_CR22","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12886-022-02703-5","volume":"22","author":"OI Haque","year":"2022","unstructured":"Haque OI, Chandrasekaran A, Nabi F, Ahmad O, Marques JP, Ahmad T. A novel compound heterozygous BEST1 gene mutation in two siblings causing autosomal recessive bestrophinopathy. BMC Ophthalmol. 2022;22(1):493.","journal-title":"BMC Ophthalmol"},{"key":"3813_CR23","first-page":"207","volume":"1","author":"RG Khayat","year":"2000","unstructured":"Khayat RG, Saxena PC. Consanguinity and its effect on infant and child mortality in Egypt. Egypt J Med Hum Genet. 2000;1:207\u201313.","journal-title":"Egypt J Med Hum Genet"},{"issue":"5","key":"3813_CR24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamaophthalmol.2014.6115","volume":"133","author":"SP Shankar","year":"2015","unstructured":"Shankar SP, Birch DG, Ruiz RS, Hughbanks-Wheaton DK, Sullivan LS, Bowne SJ, et al. Founder effect of a C. 828\u2009+\u20093A\u2009>\u2009T splice site mutation in peripherin 2 (PRPH2) C.using autosomal dominant retinal dystrophies. JAMA Ophthalmol. 2015;133(5):511\u20137.","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"3813_CR25","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1136\/jmg.2009.073619","volume":"47","author":"MJ Nevet","year":"2010","unstructured":"Nevet MJ, Shalev SA, Zlotogora J, Mazzawi N, Ben-Yosef T. Identification of a prevalent founder mutation in an Israeli Muslim Arab village confirms the role of PRCD in the aetiology of retinitis pigmentosa in humans. J Med Genet. 2010;47(8):533\u20137.","journal-title":"J Med Genet"},{"issue":"10","key":"3813_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/sj.ejhg.5200538","volume":"8","author":"DA Bessant","year":"2000","unstructured":"Bessant DA, Payne AM, Plant C, Bird AC, Swaroop A, Bhattacharya SS. NRL S50T mutation and the importance of \u2018founder effects\u2019 in inherited retinal dystrophies. Eur J Hum Genet. 2000;8(10):783\u20137.","journal-title":"Eur J Hum Genet"},{"issue":"12","key":"3813_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1167\/iovs.64.12.37","volume":"64","author":"J Shi","year":"2023","unstructured":"Shi J, Tian L, Sun T, Zhang X, Xu K, Xie Y, et al. Comprehensive genetic analysis unraveled the missing heritability and a founder variant of BEST1 in a Chinese cohort with autosomal recessive bestrophinopathy. Invest Ophthalmol Vis Sci. 2023;64(12):37.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3813_CR28","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/humu.23903","volume":"41","author":"D Sharon","year":"2020","unstructured":"Sharon D, Ben-Yosef T, Goldenberg\u2010Cohen N, Pras E, Gradstein L, Soudry S, et al. A nationwide genetic analysis of inherited retinal diseases in Israel as assessed by the Israeli inherited retinal disease consortium (IIRDC). Hum Mutat. 2020;41(1):140\u20139.","journal-title":"Hum Mutat"},{"key":"3813_CR29","doi-asserted-by":"crossref","unstructured":"Hufendiek K, Hufendiek K, J\u00e4gle H, St\u00f6hr H, Book M, Spital G et al. Clinical heterogeneity in autosomal recessive bestrophinopathy with biallelic mutations in the BEST1 gene. Int J Mol Sci. 2020;21(24).","DOI":"10.3390\/ijms21249353"},{"issue":"1","key":"3813_CR30","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s10633-014-9444-z","volume":"129","author":"C Crowley","year":"2014","unstructured":"Crowley C, Paterson R, Lamey T, McLaren T, De Roach J, Chelva E, et al. Autosomal recessive bestrophinopathy associated with angle-closure glaucoma. Doc Ophthalmol. 2014;129(1):57\u201363.","journal-title":"Doc Ophthalmol"},{"key":"3813_CR31","doi-asserted-by":"publisher","first-page":"1177711","DOI":"10.3389\/fcell.2023.1177711","volume":"11","author":"K Sarici","year":"2023","unstructured":"Sarici K, Vyas A, Iannaccone A. The double-edged sword of inflammation in inherited retinal degenerations: clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications. Front Cell Dev Biol. 2023;11:1177711.","journal-title":"Front Cell Dev Biol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03813-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03813-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03813-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,25]],"date-time":"2025-05-25T07:55:04Z","timestamp":1748159704000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03813-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,25]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3813"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03813-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,25]]},"assertion":[{"value":"6 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Medical Research Ethics Committee of The National Research Centre, Federal Wide Assurance (FWA) 00014747, RHDIRB: 2017103002 (Approval Number of the study: 13060158). It is in accordance with the provisions of the relevant Egyptian laws and with Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"A written informed consent was obtained from all patients or their guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}